http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005232181-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f4c2477bdea308bc9dec3feded37457 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 |
| filingDate | 2005-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5dfc2dc6a15b1241e3e6591ad210868f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9421e3d286908a394a2629056e06ac50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d720dbbbbc1dd0189336591915be22c0 |
| publicationDate | 2005-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2005232181-A |
| titleOfInvention | Anti-osteoporosis agent |
| abstract | [PROBLEMS] To provide an anti-osteoporosis agent having high clinical efficacy and safety. Polyisoprenoid derivatives such as 2-methyl-3 (3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenyl) -1,4-naphthoquinone, or 2, Anti-osteoporosis containing as an active ingredient one of 3-dimethoxy-5-methyl-6- (3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenyl) -1,4-benzoquinone Agent. [Selection figure] None |
| priorityDate | 2005-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 96.